177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma von Malenge, Marion M, Patzke, Sebastian, Ree, Anne H, Stokke, Trond, Ceuppens, Peter, Middleton, Brian, Dahle, Jostein, Repetto-Llamazares, Ada HV

Volltext

Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma von Repetto-Llamazares, Ada H V, Larsen, Roy H, Patzke, Sebastian, Fleten, Karianne G, Didierlaurent, David, Pichard, Alexandre, Pouget, Jean Pierre, Dahle, Jostein

Volltext

Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro von Malenge, Marion M, Maaland, Astri Fjelde, Repetto-Llamazares, Ada, Middleton, Brian, Nijland, Marcel, Visser, Lydia, Patzke, Sebastian, Heyerdahl, Helen, Kolstad, Arne, Stokke, Trond, Ree, Anne Hansen, Dahle, Jostein

Volltext

Combination of 177Lu‐lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non‐Hodgkin's lymphoma von Repetto‐Llamazares, Ada H. V., Malenge, Marion M., O'Shea, Adam, Eiríksdóttir, Bergthóra, Stokke, Trond, Larsen, Roy H., Dahle, Jostein

Volltext

Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma von Dahle, Jostein, Repetto-Llamazares, Ada H V, Mollatt, Camilla S, Melhus, Katrine B, Bruland, Oyvind S, Kolstad, Arne, Larsen, Roy H

Volltext

177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice von Repetto-Llamazares, Ada H V, Larsen, Roy H, Giusti, Anna Maria, Riccardi, Elena, Bruland, Øyvind S, Selbo, Pål Kristian, Dahle, Jostein

Volltext

Experimental studies on shear failure of freeze-bonds in saline ice: Part I. Set-up, failure mode and freeze-bond strength von Repetto-Llamazares, Ada H.V., Høyland, Knut V., Evers, Karl-Ulrich

Volltext

177 Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma von Malenge, Marion M, Patzke, Sebastian, Ree, Anne H, Stokke, Trond, Ceuppens, Peter, Middleton, Brian, Dahle, Jostein, Repetto-Llamazares, Ada H V

Volltext

Experimental studies on shear failure of freeze-bonds in saline ice: Part II: Ice-ice friction after failure and failure energy von REPETTO-LLAMAZARES, Ada H. V, HØYLAND, Knut V, KIM, Ekaterina

Volltext

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest von Pichard, Alexandre, Marcatili, Sara, Karam, Jihad, Constanzo, Julie, Ladjohounlou, Riad, Courteau, Alan, Jarlier, Marta, Bonnefoy, Nathalie, Patzke, Sebastian, Stenberg, Vilde, Coopman, Peter, Cartron, Guillaume, Navarro-Teulon, Isabelle, Repetto-Llamazares, Ada, Heyerdahl, Helen, Dahle, Jostein, Bardiès, Manuel, Pouget, Jean-Pierre

Volltext

Qualitative Description of a Shoulder Ice Barrier-Ice Interaction During Model Tests von Repetto-Llamazares, Ada H. V, Gürtner, Arne, Tobias Gudmestad, Ove, Høyland, Knut V

Volltext

Combination of 177 Lu-lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non-Hodgkin's lymphoma von Repetto-Llamazares, Ada H V, Malenge, Marion M, O'Shea, Adam, Eiríksdóttir, Bergthóra, Stokke, Trond, Larsen, Roy H, Dahle, Jostein

Volltext

Experimental studies on shear failure of freeze-bonds in saline ice von Repetto-Llamazares, Ada H.V., Høyland, Knut V., Kim, Ekaterina

Volltext

B-Cell Targeting Anti-CD37 Humanized Antibodies Engineered for Potent Effector Functions and Extended Plasma Half-Life von Fiorito, Elisa, Generalov, Roman, Foss, Stian, Heyerdahl, Helen, Repetto-Llamazares, Ada, Pascal, Veronique, Tjønnfjord, Geir E, Skånland, Sigrid Strand, Andersen, Jan Terje, Dahle, Jostein

Volltext

NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies von Generalov, Roman, Fiorito, Elisa, Foss, Stian, Pascal, Veronique, Heyerdahl, Helen, Repetto-Llamazares, Ada, Andersen, Jan Terje, Tjønnfjord, Geir E, Skånland, Sigrid Strand, Dahle, Jostein

Volltext

Anti-CD37 radioimmunotherapy with .sup.177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro von Malenge, Marion M, Maaland, Astri Fjelde, Repetto-Llamazares, Ada, Middleton, Brian, Nijland, Marcel, Visser, Lydia, Patzke, Sebastian, Heyerdahl, Helen, Kolstad, Arne, Stokke, Trond, Ree, Anne Hansen, Dahle, Jostein

Volltext

Combination of 177Lu-lilotomab satetraxetan with rituximab synergistically improves in-vivo therapeutic efficacy in a rituximab-resistant non-Hodgkin lymphoma (NHL) model von Malenge, Marion, Ree, Anne, Stokke, Trond, Dahle, Jostein, Repetto-Llamazares, Ada

Volltext

Re-Evaluation of CD37 As Target for Radioimmunotherapy of Non-Hodgkin Lymphoma von Dahle, Jostein, Repetto, Ada, Mollatt, Camilla Sivertsen, Melhus, Katrine Brustad, Bruland, Øyvind Sverre, Kolstad, Arne, Larsen, Roy Hartvig

Volltext

Combination of 177lutetium-Satetraxetan-Lilotomab and Rituximab Results in Improved Therapeutic Effect in Preclinical Models of Non-Hodgkin Lymphoma von Repetto-Llamazares, Ada H.V., Larsen, Roy Hartvig, O'Shea, Adam, Dahle, Jostein

Volltext

Abstract 5432: Targeted alpha therapy with 212Pb-NNV003 in treatment of NHL von Dahle, Jostein, Saidi, Amal, Stallons, Tania, Heyerdahl, Helen, Repetto-Llamazares, Ada, Torgue, Julien

Volltext